Director/PDMR Shareholding
April 30 2010 - 6:03AM
UK Regulatory
TIDMAKT
RNS Number : 1435L
Ark Therapeutics Group PLC
30 April 2010
30 April 2010
Ark Therapeutics Group plc
Transaction by Person Discharging Managerial Responsibilities
Disclosure Rules DTR 3.1.4R
Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company") announces that it
was informed on 23 April 2010 that Dr Nigel Parker, CEO, exercised options over
260,000 ordinary Ark shares of 1 pence each on 23 April 2010 in London at an
exercise price of 0.0001 pence per share. The option, which was granted to Dr
Parker in April 2000, was due to expire on 25 April 2010, if not exercised
before then. These shares represent approximately 0.12% of the Company's issued
share capital. Following the purchase of these shares, Dr Parker will own
3,154,579 ordinary Ark shares, representing 1.51% of the Company's issued share
capital.
Martyn Williams
Company Secretary
Ark Therapeutics Group plc
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBBGDSBGXBGGG
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Premier Veterinary Group Plc (London Stock Exchange): 0 recent articles
More Ark Therapeutics News Articles